The annual J.P. Morgan Healthcare Conference, often called the Superbowl of biotech, kicked off on Jan. 8, 2018.

Over 450 companies will be presenting, including Celgene (NASDAQ:CELG), Pfizer (NYSE:PFE), and Johnson & Johnson (NYSE:JNJ), and over 9,000 people (including The Motley Fool's Kristine Harjes) will be attending. But don't worry -- The Motley Fool's healthcare team will keep you informed about the most important announcements and analysis. Check back daily for updates!

Union Square in San Francisco

Union Square, San Francisco, home of the J.P. Morgan Healthcare Conference. Image source: Getty Images.

P.S. If you're interested in checking out how much things have changed since this time in 2017, here's last year's landing page.

Kristine Harjes owns shares of Gilead Sciences and Johnson & Johnson. The Motley Fool owns shares of and recommends Celgene, Gilead Sciences, Illumina, and Johnson & Johnson. The Motley Fool recommends Vertex Pharmaceuticals. The Motley Fool has a disclosure policy.